PAVmed Inc.
PAVM
$0.71
$0.034.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -97.78% | 694.80% | 28.83% | -8.38% | 20.57% |
| Total Depreciation and Amortization | -71.01% | -21.97% | -47.95% | -19.17% | -1.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.60% | -10,152.95% | -162.51% | 265.79% | -115.38% |
| Change in Net Operating Assets | 307.13% | -22.99% | -211.64% | -82.20% | 53.58% |
| Cash from Operations | 101.06% | 23.79% | 11.08% | -10.40% | -7.08% |
| Capital Expenditure | 33.33% | -100.00% | 92.86% | 77.05% | -916.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 100.00% | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -- | -- | -200.00% |
| Cash from Investing | 99.98% | -537,733.33% | 92.86% | 77.05% | -916.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 35.09% | -307.59% | -- |
| Issuance of Common Stock | 16.20% | 43.43% | -76.65% | 131.06% | 376.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -37.19% | 270.44% | 1,718.18% |
| Cash from Financing | 16.20% | -97.56% | -38.99% | 260.21% | 1,402.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.70% | -66,748.65% | -100.63% | 187.12% | 37.06% |